Low-dose-melphalan-induced up-regulation of type-1 cytokine expression in the s.c. tumor nodule of MOPC-315 tumor bearers and the role of interferon gamma in the therapeutic outcome.

Gorelik, L

Low-dose-melphalan-induced up-regulation of type-1 cytokine expression in the s.c. tumor nodule of MOPC-315 tumor bearers and the role of interferon gamma in the therapeutic outcome. [electronic resource] - Cancer immunology, immunotherapy : CII Dec 1995 - 363-74 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0340-7004

10.1007/BF01526556 doi


Animals
Antineoplastic Agents, Alkylating--administration & dosage
Base Sequence
Cytotoxicity, Immunologic--drug effects
Female
Gene Expression Regulation, Neoplastic--drug effects
Injections, Subcutaneous
Interferon-gamma--antagonists & inhibitors
Melphalan--administration & dosage
Mice
Mice, Inbred BALB C
Molecular Sequence Data
Neoplasm Transplantation
Plasmacytoma--immunology
Polymerase Chain Reaction
RNA, Messenger--biosynthesis
Stimulation, Chemical
T-Lymphocytes, Cytotoxic--drug effects
Tumor Cells, Cultured
Tumor Necrosis Factor-alpha--biosynthesis